Home | Myriad Genetics - When Decisions Matter
  • Patients
    • Patient Questions
      • What’s My Risk?
      • Do I Have A Disease?
      • How Aggressive is My Disease?
      • How Should I Treat My Disease?
    • Genetic Testing 101
      • Genes & Disease
      • Benefits of Genetic Testing
      • Genetic Testing FAQs
      • Real Patient Stories
    • Resources
      • Hereditary Cancer Quiz
      • Women’s Health Resources
      • Depression Resources
      • Oncology Resources
      • Melanoma Resources
      • Rheumatoid Arthritis Resources
      • Prostate Cancer Resources
    • Affordability
      • The Myriad Promise
      • Financial Assistance Program
  • Providers
    • Patient Care
      • Predicting Disease
      • Diagnosing Disease
      • Assessing Prognosis
      • Precision Medicine
      • Genetic Testing Process
    • Resources
      • MyriadPro™
      • Hereditary Cancer Quiz
      • Order a Test Kit
      • Lab Certificates
      • MyVision
  • Products
    • Myriad Products
      • Breast Cancer
        • EndoPredict®
      • Carrier Screen
        • Foresight®
      • Depression
        • GeneSight®
      • Melanoma
        • myPath®
      • Hereditary Cancers
        • myRisk®
        • riskScore®
        • BRACAnalysis®
        • COLARIS®
        • COLARIS AP®
      • Precision Medicine
        • BRACAnalysis CDx®
        • myChoice® CDx
      • Prenatal Screen
        • PrequelTM
      • Prostate Cancer
        • Prolaris®
      • Rheumatoid Arthritis
        • Vectra®
  • About
    • Company
      • About Myriad Genetics
      • Company Fact Sheet
      • History
      • Executive Team
      • Board of Directors
    • Global Presence
      • Myriad International
      • Myriad Japan
    • Myriad Cares
      • Corporate Social Responsibility
      • Patient Advocacy
      • Policy on Genetic Information
  • Contact
    • Offices
      • Corporate Offices
      • International Offices
    • Divisions
      • Billing
      • Customer Service
      • International
      • Medical Records
      • Medical Services
      • Myriad Autoimmune
      • Myriad Neuroscience
      • Myriad Women’s Health
      • Myriad RBM
    • Address
      • Myriad Genetics, Inc.
        320 Wakara Way
        Salt Lake City, UT 84108
    • Phone
      • (800) 4-MYRIAD
      • (800) 469-7423
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Patients
    • Patient Questions
      • What’s My Risk?
      • Do I Have A Disease?
      • How Aggressive is My Disease?
      • How Should I Treat My Disease?
    • Genetic Testing 101
      • Genes & Disease
      • Benefits of Genetic Testing
      • Genetic Testing FAQs
      • Real Patient Stories
    • Resources
      • Hereditary Cancer Quiz
      • Women’s Health Resources
      • Depression Resources
      • Oncology Resources
      • Melanoma Resources
      • Rheumatoid Arthritis Resources
      • Prostate Cancer Resources
    • Affordability
      • The Myriad Promise
      • Financial Assistance Program
  • Providers
    • Patient Care
      • Predicting Disease
      • Diagnosing Disease
      • Assessing Prognosis
      • Precision Medicine
      • Genetic Testing Process
    • Resources
      • MyriadPro™
      • Hereditary Cancer Quiz
      • Order a Test Kit
      • Lab Certificates
      • MyVision
  • Products
    • Myriad Products
      • Breast Cancer
        • EndoPredict®
      • Carrier Screen
        • Foresight®
      • Depression
        • GeneSight®
      • Melanoma
        • myPath®
      • Hereditary Cancers
        • myRisk®
        • riskScore®
        • BRACAnalysis®
        • COLARIS®
        • COLARIS AP®
      • Precision Medicine
        • BRACAnalysis CDx®
        • myChoice® CDx
      • Prenatal Screen
        • PrequelTM
      • Prostate Cancer
        • Prolaris®
      • Rheumatoid Arthritis
        • Vectra®
  • About
    • Company
      • About Myriad Genetics
      • Company Fact Sheet
      • History
      • Executive Team
      • Board of Directors
    • Global Presence
      • Myriad International
      • Myriad Japan
    • Myriad Cares
      • Corporate Social Responsibility
      • Patient Advocacy
      • Policy on Genetic Information
  • Contact
    • Offices
      • Corporate Offices
      • International Offices
    • Divisions
      • Billing
      • Customer Service
      • International
      • Medical Records
      • Medical Services
      • Myriad Autoimmune
      • Myriad Neuroscience
      • Myriad Women’s Health
      • Myriad RBM
    • Address
      • Myriad Genetics, Inc.
        320 Wakara Way
        Salt Lake City, UT 84108
    • Phone
      • (800) 4-MYRIAD
      • (800) 469-7423
Investors > News Releases

News Releases

Feb 23, 2021
Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
Financial
Feb 18, 2021
Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth Initiatives
Corporate
Feb 16, 2021
Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021
Financial
Feb 12, 2021
New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics’ Prolaris® test to Guide Treatment for Prostate Cancer
Pipeline
Feb 11, 2021
Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences
Corporate
Feb 08, 2021
GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels
Products
Feb 02, 2021
Myriad Genetics Launches New Vectra® Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis
Products
Jan 19, 2021
Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in Japan
Products
Jan 11, 2021
Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
Products
Jan 08, 2021
Myriad Genetics Receives First Reimbursement Decision for myChoice® Diagnostic System in Japan, Enabling Women with Ovarian Cancer to Benefit from Treatment with Zejula®
Products
Jan 05, 2021
Myriad Genetics Provides Transformation Update, Pursues Strategic Alternatives for Autoimmune Business, Realigns International Operations
Corporate
Jan 04, 2021
Myriad Genetics CEO Paul J. Diaz to Present at 39th Annual J.P. Morgan Healthcare Conference
Corporate
Dec 11, 2020
New Study Provides Personalized Breast Cancer Risk Information for Women with ATM Gene Mutations
Pipeline
Nov 17, 2020
Suffering in Silence: Two-Thirds of Older Adults Say They Won’t Treat Their Depression
Products
Nov 16, 2020
Myriad Genetics Announces Global Expansion of Myriad myChoice® Tumor Testing in Europe and China
Pipeline
Next page
  • Payers
  • Overview
  • Clinical Data
  • Health Economics
  • Medical Guidelines
  • Coverage + Billing
  • Payer News
  • Partners
  • Research
  • Companion Diagnostics
  • Academic Collaborations
  • Licensing
  • Investors
  • Financial Reporting
  • Stock Information
  • Events + Presentations
  • Investor FAQs
  • News
  • Press Releases
  • Myriad Genetics Blog
  • Company Logos
  • Career
  • Joining the Team
Myriad Genetics Logo
  • Terms of Use
  • Privacy Policy
  • Language Assistance
© 2021 Myriad Genetics, Inc.

Website Feedback








reCAPTCHA helps prevent automated form spam.
The submit button will be disabled until you complete the CAPTCHA.

Contact Information